Regencell Bioscience Holdings Limited
General ticker "RGC" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $4.3B (TTM average)
Regencell Bioscience Holdings Limited follows the US Stock Market performance with the rate: 25.6%.
Estimated limits based on current volatility of 10.2%: low 12.35$, high 15.16$
Factors to consider:
- Total employees count: 13 as of 2021
Short-term RGC quotes
Long-term RGC plot
Financial data
| YTD | 2022-06-30 | 2023-06-30 | 2024-06-30 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $7.62MM | $6.27MM | $4.74MM |
| Operating Income | $-7.62MM | $-6.27MM | $-4.74MM |
| Non-Operating Income | $0.02MM | $0.21MM | $0.37MM |
| R&D Expense | $2.51MM | $1.58MM | $1.07MM |
| Income(Loss) | $-7.59MM | $-6.06MM | $-4.36MM |
| Profit(Loss)* | $-7.42MM | $-5.87MM | $-4.30MM |
| Stockholders Equity | $17.07MM | $12.03MM | $8.22MM |
| Inventory | $0.03MM | $0.06MM | $0.00MM |
| Assets | $18.02MM | $12.62MM | $8.44MM |
| Operating Cash Flow | $-5.27MM | $-4.96MM | $-4.00MM |
| Capital expenditure | $0.78MM | $0.03MM | $0.01MM |
| Investing Cash Flow | $-10.78MM | $0.06MM | $5.24MM |
| Financing Cash Flow | $22.41MM | $0.13MM | $0.10MM |
| Earnings Per Share** | $-0.02 | $-0.01 | $-0.01 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.